Physician profile
John M Lee
NPI 1679764948
$9,659.27
in general payments reported to CMS, 2019-2025
40 companies · $1,488 in 2025
The $1,488 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,135 · 2020: $1,329 · 2021: $265 · 2022: $1,142 · 2023: $1,633 · 2024: $1,667 · 2025: $1,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,787.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,780.99 | 2019-2025 | Avvigo Guidance System, General - Balloon Catheters |
| Amgen INC. | $892.41 | 2019-2025 | Repatha, Repatha |
| Abiomed | $817.34 | 2021-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $590.20 | 2019-2025 | |
| Medtronic, INC. | $579.17 | 2023-2025 | Onyx Frontier, Linq II, Micra |
| Abbott Laboratories | $509.20 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Dragonfly Opstar, Jot Dx |
| Pfizer INC. | $351.80 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $305.90 | 2019-2024 | Farxiga, Brilinta, Andexxa |
| Merck Sharp & Dohme LLC | $273.44 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $271.78 | 2019-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $264.47 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $232.41 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $193.40 | 2019-2025 | Lifevest |
| Biotronik INC. | $156.90 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $149.98 | 2022-2023 | Arcalyst |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $124.95 | 2022-2023 | Ffrct |
| Cardiva Medical, INC. | $109.33 | 2019-2022 | |
| Medtronic Vascular, INC. | $108.69 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.89 | 2019-2024 | Jardiance |
| Astellas Pharma US INC | $97.60 | 2019-2021 | |
| Novo Nordisk INC | $96.32 | 2024-2025 | Ozempic, Rybelsus |
| Philips North America LLC | $84.00 | 2019-2025 | Extended Holter |
| Kestra Medical Technology Services, INC. | $68.21 | 2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $49.71 | 2022-2023 | Onpattro |
| Irhythm Technologies, INC. | $48.69 | 2023 | Zio Xt Patch |
| Lexicon Pharmaceuticals, INC. | $47.78 | 2024 | |
| Davol INC. | $45.68 | 2025 | Arista |
| Medicomp INC | $43.00 | 2024 | Telepatch Cardiac Monitor |
| Atricure, INC. | $31.78 | 2024 | |
| Recor Medical INC | $29.17 | 2025 | Paradise Ultrasound Renal Denervation System |
| Glaxosmithkline, LLC. | $26.47 | 2025 | Arexvy |
| Becton, Dickinson and Company | $25.85 | 2024 | Rotarexs 6 F X 135 Cm |
| Kiniksa Pharmaceuticals International, Plc | $22.59 | 2024 | Arcalyst |
| Cvrx, INC. | $21.46 | 2024 | Barostim Neo System |
| Cordis US Corp. | $18.21 | 2024 | Rain Sheath |
| Edwards Lifesciences Corporation | $17.75 | 2019 | |
| Esperion Therapeutics, INC. | $17.13 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.95 | 2019 | |
| Scpharmaceuticals INC. | $16.26 | 2025 | |
| Chiesi USA, INC. | $14.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.